China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate ...

Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s ...

China to block Chinese firms from investing in the U.S. amid tariff war; Shenzhen launches incentives for foreign-owned ...

Cybersecurity Law amendment draft imposes heavier penalties. China proposes different data protection periods for three categories of drugs. Facial information collection requires obligations of ...

State Council restricts provision of evidence outside of mainland China for IP cases / CLP Reference: 5100/25.03.13 ; Promulgated: 2025-03-13 ; Effective: 2025-05-01 ...

Hong Kong stock market rebounds when Chinese government halts Swiss listings; China backs AI with government investment fund; and China’s Supreme People’s Court further protects intellectual property ...

Headquarters with research and development functions shall be supported in applying for recognition as high-tech enterprises or technologically advanced service enterprises, and shall be eligible for ...